These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria. Demirci E; Akyel R; Caner B; Alan-Selçuk N; Güven-Meşe Ş; Ocak M; Kabasakal L Nucl Med Commun; 2020 Aug; 41(8):759-767. PubMed ID: 32453205 [TBL] [Abstract][Full Text] [Related]
69. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328 [TBL] [Abstract][Full Text] [Related]
71. Udovicich C; Perera M; Hofman MS; Siva S; Del Rio A; Murphy DG; Lawrentschuk N Prostate Int; 2017 Dec; 5(4):125-129. PubMed ID: 29188197 [TBL] [Abstract][Full Text] [Related]
72. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence. Uprimny C; Kroiss AS; Fritz J; Decristoforo C; Kendler D; von Guggenberg E; Nilica B; Maffey-Steffan J; di Santo G; Bektic J; Horninger W; Virgolini IJ Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1647-1655. PubMed ID: 28589253 [TBL] [Abstract][Full Text] [Related]
73. Akdemir EN; Tuncel M; Akyol F; Bilen CY; Baydar DE; Karabulut E; Ozen H; Caglar M World J Urol; 2019 May; 37(5):813-821. PubMed ID: 30151600 [TBL] [Abstract][Full Text] [Related]
74. Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer. Park SY; Zacharias C; Harrison C; Fan RE; Kunder C; Hatami N; Giesel F; Ghanouni P; Daniel B; Loening AM; Sonn GA; Iagaru A Radiology; 2018 Aug; 288(2):495-505. PubMed ID: 29786490 [TBL] [Abstract][Full Text] [Related]
76. Early dynamic imaging in Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519 [TBL] [Abstract][Full Text] [Related]
77. The effect of androgen deprivation therapy on Onal C; Guler OC; Torun N; Reyhan M; Yapar AF Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):632-641. PubMed ID: 31732768 [TBL] [Abstract][Full Text] [Related]
78. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398 [TBL] [Abstract][Full Text] [Related]
79. Establishment and prospective validation of an SUV Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749 [No Abstract] [Full Text] [Related]